3D bioprinting allows researchers to create custom 3D tissues for research, investigate new disease models, formulate the next generation of bioinks, and study the body outside the body with a level of freedom and ease-of-use that was simply not possible as recently as 10 years ago.
Since we launched our first bioprinter, the first commercial desktop bioprinter in the world, our incredible community of users all over the globe has worked on groundbreaking research for the development of sugar stents to one day help surgeons join veins with fewer complications, systems for improved drug delivery, disease models for drug screening, and the bioprinting of tissues with translational aspirations in regenerative medicine. Check out our publications page to learn more about the work our users are doing.
Allevi by 3D Systems recognizes the power of democratizing technologies for scientists. We are proud partners of research institutions worldwide, enabling the study of bioprinting to one day achieve the enormous goals we have for the field: producing tissues that can better recapitulate human physiology for more effective drug testing, 3D bioprinting drug delivery systems for efficient and guided application of drugs to pathological sites, and printing tissues for regenerative (and personalized) medicine.